The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs (Q30661462)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

1 reference

based on heuristic

inferred from title

author name string

Bélec L

1

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Maletinska L

2

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Slaninová J

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Lubell WD

4

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Chemical Biology and Drug Design

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

263-273

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

Topographically designed analogs of [cyclic] [D-Pen2,D-Pen5]enkephalin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

A study of the relationship between biological activity and prolyl amide isomer geometry in oxytocin using 5-tert-butylproline to augment the Cys(6)-Pro(7) amide cis-isomer population

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Use of Steric Interactions To Control Peptide Turn Geometry. Synthesis of Type VI beta-Turn Mimics with 5-tert-Butylproline.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Conformational Aspects of Differences in Requirements for Oxytocin and Vasopressin Receptors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

21 January 2018

Pseudoprolines: Targeting acis Conformation in a Mimetic of the gp120 V3 Loop of HIV-1

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and Some Pharmacological Properties of 6-L-Penicillamine-oxytocin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of 1-L-penicillamine-oxytocin, 1-D-penicillamine-oxytocin, and 1-deaminopenicillamine-oxytocin, potent inhibitors of the oxytocic response of oxytocin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a D-Cys6/L-Cys6 interchange in nonselective and selective vasopressin and oxytocin antagonists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3011.2001.00932.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1399-3011.2001.00932.X

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30661462&oldid=2046601293"